109 related articles for article (PubMed ID: 2272769)
1. A phase II study of mitoxantrone in advanced gastric cancer.
Levi JA; Gill PG; Presgrave P
Invest New Drugs; 1990 Aug; 8(3):305-6. PubMed ID: 2272769
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of mitoxantrone in advanced gastric cancer.
Goldenberg A; Kelsen D; Benedetto P
Oncology; 1988; 45(4):273-5. PubMed ID: 3290754
[TBL] [Abstract][Full Text] [Related]
3. Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: a Southwest Oncology Group study.
Taylor SA; Fleming T; Von Hoff DD; McCracken JD; Bukowski RM; Talley RW; Natale RB; Guy JT; Samlowski WE; Costanzi JH
Invest New Drugs; 1990 Feb; 8(1):77-80. PubMed ID: 2188928
[TBL] [Abstract][Full Text] [Related]
4. Mitoxantrone in the treatment of advanced non-squamous carcinoma of the cervix (a phase II trial of the gynecologic oncology group).
Muss HB; Bundy BN; Homesley HD; Wilbanks G
Invest New Drugs; 1987; 5(2):199-202. PubMed ID: 3654152
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of doxorubicin, bisantrene, and mitoxantrone in advanced breast cancer: a Southwest Oncology Group study.
Cowan JD; Neidhart J; McClure S; Coltman CA; Gumbart C; Martino S; Hutchins LF; Stephens RL; Vaughan CB; Osborne CK
J Natl Cancer Inst; 1991 Aug; 83(15):1077-84. PubMed ID: 1875415
[TBL] [Abstract][Full Text] [Related]
6. Phase II trials of 5-FU, doxorubicin, and cisplatin in advanced, measurable adenocarcinoma of the lung and stomach.
Cazap EL; Gisselbrecht C; Smith FP; Estevez RA; Alvarez CA; Lagarde C; Hannois A; Ahmed S; Schein PS; Woolley PV
Cancer Treat Rep; 1986 Jun; 70(6):781-3. PubMed ID: 3524826
[TBL] [Abstract][Full Text] [Related]
7. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.
Henderson IC; Allegra JC; Woodcock T; Wolff S; Bryan S; Cartwright K; Dukart G; Henry D
J Clin Oncol; 1989 May; 7(5):560-71. PubMed ID: 2468745
[TBL] [Abstract][Full Text] [Related]
8. Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282.
Novik Y; Ryan LM; Haller DG; Asbury R; Dutcher JP; Schutt A
Med Oncol; 1999 Dec; 16(4):261-6. PubMed ID: 10618689
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of mitoxantrone in advanced squamous cell cancer of the head and neck.
Wheeler H; Woods RL; Page J; Levi J
Invest New Drugs; 1990 Feb; 8(1):109-11. PubMed ID: 2345066
[TBL] [Abstract][Full Text] [Related]
10. Phase II study of weekly paclitaxel plus 24-h continuous infusion 5-fluorouracil, folinic acid and 3-weekly cisplatin for the treatment of patients with advanced gastric cancer.
Honecker F; Kollmannsberger C; Quietzsch D; Haag C; Schroeder M; Spott C; Hartmann JT; Baronius W; Hempel V; Kanz L; Bokemeyer C
Anticancer Drugs; 2002 Jun; 13(5):497-503. PubMed ID: 12045461
[TBL] [Abstract][Full Text] [Related]
11. [Phase II clinical trial on mitoxantrone].
Gao HR
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):204-6. PubMed ID: 2693025
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced gastric cancer with DDP (cisplatin), adriamycin, and 5-fluorouracil (DAF).
Epelbaum R; Haim N; Stein M; Cohen Y; Robinson E
Oncology; 1987; 44(4):201-6. PubMed ID: 3614811
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
[TBL] [Abstract][Full Text] [Related]
14. Phase II study of mitoxantrone in advanced or metastatic endometrial carcinoma.
Boadle DJ; Tattersall MH
Aust N Z J Obstet Gynaecol; 1987 Nov; 27(4):341-2. PubMed ID: 3453676
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion.
Wilson WH; Berg SL; Bryant G; Wittes RE; Bates S; Fojo A; Steinberg SM; Goldspiel BR; Herdt J; O'Shaughnessy J
J Clin Oncol; 1994 Aug; 12(8):1621-9. PubMed ID: 7913721
[TBL] [Abstract][Full Text] [Related]
16. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
17. An EORTC phase II study of mitoxantrone in solid tumors and lymphomas.
De Jager R; Cappelaere P; Armand JP; Keiling R; Fargeot P; Bastit P; van Glabbeke M; Renard J; Earl H; Rubens R
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1369-75. PubMed ID: 6542006
[TBL] [Abstract][Full Text] [Related]
18. Bi-weekly chemotherapy with cisplatin, epirubicin, folinic acid and 5-fluororacil continuous infusion plus g-csf in advanced gastric cancer: a multicentric phase II study.
Felici A; Carlini P; Ruggeri EM; Gamucci T; Pollera CF; De Marco S; Fariello AM; Moscetti L; Gelibter A; Adami E; Sperduti I; Cognetti F
Cancer Chemother Pharmacol; 2006 Jan; 57(1):59-64. PubMed ID: 16001173
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of adriamycin with sequential methotrexate and 5-fluorouracil (AMF) in gastric carcinoma.
Ajani JA; Goudeau P; Levin B; Faintuch JS; Abbruzzese JL; Boman BM; Kanojia MD
Cancer Chemother Pharmacol; 1989; 24(1):41-4. PubMed ID: 2720890
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancer.
Bokemeyer C; Hartmann JT; Lampe CS; Clemens MR; Quietzsch D; Forkmann L; Kanz L
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-96-S19-100. PubMed ID: 9427277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]